"私が知るほど あなたも知るほど" 黒人コミュニティの臨床試験に対する意識を高めるツールを開発するために 文化に敏感なマーケティング戦略を活用する
Vida Henderson1, Leslie Carnahan2, Eliza Brumer Cohn3
1Fred Hutchinson Cancer Center, Public Health Sciences Division, 1100 Fairview Ave N., Seattle, WA, 98109, USA. vahender@fredhutch.org.
BMC public health
|September 1, 2025
まとめ
マーケティング戦略は 黒人コミュニティの癌臨床試験の意識を高めることができます 文化に敏感なPSAビデオは 聴衆を効果的に惹きつけ 参加の障壁を克服します
科学分野:
- 健康 コミュニケーション
- 健康に関する公平性
- 癌の研究の普及
背景:
- 癌の研究の非効率的な普及は 健康上の不平等を助長しています
- 黒人アメリカ人は最も高い癌死亡率に直面していますが,臨床試験では代表が不足しています (5%).
- 非研究対象者の参加は 効果的な普及に不可欠です
研究 の 目的:
- 黒人視聴者の間でがん臨床試験の意識を高めるためのマーケティング戦略を使用して,文化的に反応する公共サービス発表 (PSA) ビデオを作成します.
- 対象コミュニティが特定した臨床試験への参加の障壁を解決する.
主な方法:
- マーケティング戦略の枠組みと マーケティングと臨床試験の基準モデルを利用した.
- 黒人がん生存者とコミュニティのメンバーを対象に6つのフォーカスグループを運営し,PSA開発の段階的なインプットを行いました.
- スクリプトとビデオコンテンツをガイドするテーマを特定するために素早い定性データ分析を使用しました.
主要な成果:
- プロの俳優とストーリーテリングを使って 30秒と60秒のPSAビデオを制作しました.
- ビデオは臨床試験を効果的に説明し 統計を提示し 障壁に対処し 資源を提供しました
- 参加者はPSAが魅力的で 分かりやすく 議論を巻き起こし 情報共有を促すものだと考えました
結論:
- マーケティング・コミュニケーション・ 戦略は 意義のある 量身の健康情報を作るための 実用的なアプローチを提供します
- この方法は,より広範で特定のオーディエンスに健康情報を効果的に広げるのに役立ちます.
- 文化に配慮したマーケティングは 医療研究への参加の格差をなくし 関与を高めることができます
関連する概念動画
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Community Based Intervention
94
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
94
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


